Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent Prostate Cancer

Clinical trial condition

Recurrent Prostate Cancer

Explore clinical trials studying Recurrent Prostate Cancer. Study availability and eligibility vary by location and protocol.

87 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Prostate Cancer trial results

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00040755

Conditions: Adenocarcinoma of the Prostate, Bone Metastases, Genital Diseases, +12 more
Locations: UC Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details

Completed

SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel

NCT00096499

Conditions: Adenocarcinoma of the Prostate, Genital Diseases, Genital Diseases, Male, +10 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors

NCT00074022

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
Locations: Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer

NCT00109811

Conditions: Adenocarcinoma of the Prostate, Genital Diseases, Genital Diseases, Male, +9 more
Locations: University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

NCT00030498

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +185 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Safety and Efficacy of POMx Capsules in Men With Recurrent Prostate Cancer: An 18-Month Study

NCT01220817

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details